Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Peter Mortimer

6PUBLICATIONS

76CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jan 27, 2026

Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

|Dec 05, 2023

Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial.

Susanne A Gatz, Anne C Harttrampf, Caroline Brard

|Mar 05, 2022

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors.

Atish D Choudhury, Celestia S Higano, Johann S de Bono

|Sep 16, 2021

Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations).

Haider Mahdi, Navid Hafez, Deborah Doroshow

|May 12, 2021

Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer.

Seung Tae Kim, Simon A Smith, Peter Mortimer

|Jul 19, 2019

Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial.

Jeeyun Lee, Seung Tae Kim, Kyung Kim

Pageof 1

Frequent Collaborators

9 joint publications

Young Saing Kim

2 joint publications

Nicolas André

2 joint publications

Emilie De Carli

2 joint publications

Souad Nebchi

2 joint publications

Jonathan Rubino

2 joint publications

Estelle Thebaud

2 joint publications

Susanne A Gatz

2 joint publications

Lynley V Marshall

2 joint publications

Kyoung-Mee Kim

2 joint publications

Geoffrey I Shapiro

Frequent Collaborators

9 joint publications

Young Saing Kim

2 joint publications

Nicolas André

2 joint publications

Emilie De Carli

2 joint publications

Souad Nebchi

Top Related Videos

Measuring Attentional Biases for Threat in Children and Adults

Measuring Attentional Biases for Threat in Children and Adults

Published on : Oct 19, 2014

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos

Top Related Videos

Measuring Attentional Biases for Threat in Children and Adults

Measuring Attentional Biases for Threat in Children and Adults

Published on : Oct 19, 2014

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

See more related videos